ConductScience.org, home

Paper17577614

The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer. Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy.

Kodera Y. Gastric Cancer, 2007. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer. Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy. Papers, record 17577614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17577614

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer. Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy.
PubMed
Journal
Gastric Cancer
PubMed
Year
2007
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kodera YYasuhiro

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Lymph Node ExcisionMajor topic
Stomach NeoplasmsMajor topic
Clinical Trials as Topic
Combined Modality Therapy
Europe
Humans
Japan
United States

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110089184Extended lymph-node dissection for gastric cancer.N Engl J Med1999https://conductscience.org/library/papers/10089184PubMed
29020913Prediction of lymph node metastasis in gastric cancer patients with neural networks.Cancer Lett1996https://conductscience.org/library/papers/9020913PubMed
315199090Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.J Clin Oncol2004https://conductscience.org/library/papers/15199090PubMed
416574546Nodal dissection for patients with gastric cancer: a randomised controlled trial.Lancet Oncol2006https://conductscience.org/library/papers/16574546PubMed
516317484Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial.World J Surg2005https://conductscience.org/library/papers/16317484PubMed
612805327Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.J Clin Oncol2003https://conductscience.org/library/papers/12805327PubMed
716099596
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/16099596PubMed
810188901Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.Br J Cancer1999https://conductscience.org/library/papers/10188901PubMed
916894366The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens.Nat Clin Pract Oncol2006https://conductscience.org/library/papers/16894366PubMed
1016275676
A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.
Jpn J Clin Oncol2005https://conductscience.org/library/papers/16275676PubMed
1111923135Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.Ann Surg Oncol2002https://conductscience.org/library/papers/11923135PubMed
1216740764Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.Clin Cancer Res2006https://conductscience.org/library/papers/16740764PubMed
13868069Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.World J Surg1977https://conductscience.org/library/papers/868069PubMed
1415698731Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries.Eur J Surg Oncol2005https://conductscience.org/library/papers/15698731PubMed
1516767367A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.Gastric Cancer2006https://conductscience.org/library/papers/16767367PubMed
1612495318Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials?J Am Coll Surg2002https://conductscience.org/library/papers/12495318PubMed
179893658Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.Eur J Cancer1998https://conductscience.org/library/papers/9893658PubMed
1817577616Improved regional control and survival with "low Maruyama Index" surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial.Gastric Cancer2007https://conductscience.org/library/papers/17577616PubMed
1914676796Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer.Br J Cancer2003https://conductscience.org/library/papers/14676796PubMed
2011547741Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med2001https://conductscience.org/library/papers/11547741PubMed

See all 24 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
20039455Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital.World J Gastroenterol2010https://conductscience.org/library/papers/20039455PubMed
20003202Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?BMC Cancer2009https://conductscience.org/library/papers/20003202PubMed
19267738Post-operative complications of gastric cancer surgery: female gender at high risk.Eur J Cancer Care (Engl)2009https://conductscience.org/library/papers/19267738PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17577614

GET https://conductscience.org/api/papers/v1/17577614/references?page=2